Neuromodulation of Inflammation and Endothelial Function

NARecruitingINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

February 27, 2026

Study Completion Date

February 27, 2026

Conditions
Systolic Heart Failure
Interventions
DEVICE

neuromodulation device

Active LLTS will be performed by use of a neuromodulation device with electrodes attached to the tragus of the ear. Stimulator will be applied continuously for 1 hour daily for 12 weeks

DEVICE

SHAM

Sham LLTS will be performed by use of a neuromodulation device with electrodes attached to the ear lobule. Stimulator will be applied continuously for 1 hour daily for 12 weeks

Trial Locations (1)

73117

RECRUITING

University of Oklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Oklahoma

OTHER